RA Capital Nexus Fund III, Director: Mineralys Therapeutics MLYS Buy · Filed 23/02/16

Trade details

Type: Insider buy
Amount: $17,894,400
Shares · price: 1,118,400 sh · $16.00 a share
Held after: 1,311,247 sh
Stock: Mineralys Therapeutics MLYS
Person: RA Capital Nexus Fund IIIDirector
Trade date: 23/02/14
Filed: 23/02/16
Days to filing: 2 days

11 insiders bought this week

Insiders buying this week: 11 insiders
Holding change: +579.9%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/15~23/03/16

RA Capital Nexus Fund III's recent trades

RA Capital Nexus Fund IIIDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
RA Capital Nexus Fund IIIDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16